STOCK TITAN

Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Acurx Pharmaceuticals, Inc. (ACXP) President and CEO David P. Luci to present at 42nd Annual J.P. Morgan Healthcare Conference
Positive
  • None.
Negative
  • None.

STATEN ISLAND, N.Y., Jan. 3, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") today announced that President and Chief Executive Officer David P. Luci will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 12:00 pm PST. An audio webcast of the presentation will be available live at https://jpmorgan.metameetings.net/events/healthcare24/sessions/50099-acurx-pharmaceuticals-inc/webcast?gpu_only=true&kiosk=true and will be available upon completion of the conference on the Company's website at www.acurxpharma.com under the Investors section.

About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS®) that blocks the active site of the Gram+ specific bacterial enzyme DNA polymerase IIIC (pol IIIC), inhibiting DNA replication and leading to Gram-positive bacterial cell death. Its R&D pipeline includes antibiotic product candidates that target Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin resistant Enterococcus (VRE) and drug-resistant Streptococcus pneumoniae (DRSP).

To learn more about Acurx Pharmaceuticals and its product pipeline, please visit www.acurxpharma.com

Investor Contact:

Acurx Pharmaceuticals, Inc.

David P. Luci
President & CEO 
Tel: 917-533 1469
Email: davidluci@acurxpharma.com

Cision View original content:https://www.prnewswire.com/news-releases/acurx-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302024975.html

SOURCE Acurx Pharmaceuticals, Inc.

FAQ

When will President and CEO David P. Luci present at the 42nd Annual J.P. Morgan Healthcare Conference?

President and CEO David P. Luci will present on Thursday, January 11, 2024, at 12:00 pm PST.

Where can I access the live audio webcast of the presentation?

The live audio webcast will be available at https://jpmorgan.metameetings.net/events/healthcare24/sessions/50099-acurx-pharmaceuticals-inc/webcast?gpu_only=true&kiosk=true

Where can I find the webcast after the completion of the conference?

The webcast will be available on the Company's website at www.acurxpharma.com under the Investors section.

Acurx Pharmaceuticals, Inc.

NASDAQ:ACXP

ACXP Rankings

ACXP Latest News

ACXP Stock Data

13.31M
14.49M
14.8%
11.96%
2.92%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
STATEN ISLAND